Trial Profile
Phase I trial of ND L02 s0201 in Japan.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 22 Oct 2014
Price :
$35
*
At a glance
- Drugs BMS-986263 (Primary)
- Indications Hepatic fibrosis
- Focus Adverse reactions
- Sponsors Nitto Denko
- 22 Oct 2014 New trial record